These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 17115806)

  • 21. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.
    Davis M; Walker DL; Miles L; Grillon C
    Neuropsychopharmacology; 2010 Jan; 35(1):105-35. PubMed ID: 19693004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and anatomical analysis of fear conditioning.
    Davis M
    NIDA Res Monogr; 1990; 97():126-62. PubMed ID: 2247135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock.
    Davis M; Walker DL
    Brain Struct Funct; 2014 Nov; 219(6):1969-82. PubMed ID: 23934654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats.
    Yang YL; Chao PK; Ro LS; Wo YY; Lu KT
    Neuropsychopharmacology; 2007 May; 32(5):1042-51. PubMed ID: 17047672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos.
    Campeau S; Falls WA; Cullinan WE; Helmreich DL; Davis M; Watson SJ
    Neuroscience; 1997 Jun; 78(4):1087-104. PubMed ID: 9174076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis?
    Robinson OJ; Overstreet C; Allen PS; Pine DS; Grillon C
    Neuropsychopharmacology; 2012 Jul; 37(8):1963-71. PubMed ID: 22491355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.
    Zhao Z; Yang Y; Walker DL; Davis M
    Neuropsychopharmacology; 2009 Jan; 34(2):331-40. PubMed ID: 18418359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats.
    Schweimer J; Fendt M; Schnitzler HU
    Eur J Pharmacol; 2005 Jan; 507(1-3):117-24. PubMed ID: 15659301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning.
    Schauz C; Koch M
    Learn Mem; 2000; 7(6):393-9. PubMed ID: 11112798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm.
    Davis M
    Behav Neurosci; 1986 Dec; 100(6):814-24. PubMed ID: 3545257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.
    Knoll AT; Muschamp JW; Daws SE; Ferguson D; Dietz DM; Meloni EG; Carroll FI; Nestler EJ; Konradi C; Carlezon WA
    Biol Psychiatry; 2011 Sep; 70(5):425-33. PubMed ID: 21531393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala.
    Falls WA; Miserendino MJ; Davis M
    J Neurosci; 1992 Mar; 12(3):854-63. PubMed ID: 1347562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression.
    Walker DL; Paschall GY; Davis M
    Learn Mem; 2005; 12(2):120-9. PubMed ID: 15774945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm.
    Hitchcock J; Davis M
    Behav Neurosci; 1986 Feb; 100(1):11-22. PubMed ID: 3954873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex.
    Davis M; Walker DL; Lee Y
    Philos Trans R Soc Lond B Biol Sci; 1997 Nov; 352(1362):1675-87. PubMed ID: 9415919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response.
    Fendt M; Koch M; Schnitzler HU
    Eur J Pharmacol; 1996 Dec; 318(1):1-6. PubMed ID: 9007504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
    Grillon C; Hale E; Lieberman L; Davis A; Pine DS; Ernst M
    Neuropsychopharmacology; 2015 Mar; 40(5):1064-71. PubMed ID: 25430779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperexcitability: exaggerated fear-potentiated startle produced by partial amygdala kindling.
    Rosen JB; Hamerman E; Sitcoske M; Glowa JR; Schulkin J
    Behav Neurosci; 1996 Feb; 110(1):43-50. PubMed ID: 8652071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural systems involved in fear-potentiated startle.
    Davis M
    Ann N Y Acad Sci; 1989; 563():165-83. PubMed ID: 2570545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.